Literature DB >> 3917700

Interval between insulin injection and eating in relation to blood glucose control in adult diabetics.

M E Lean, L L Ng, B R Tennison.   

Abstract

In a survey of 225 diabetics treated with insulin 24 (10.6%) claimed never to have received advice concerning the interval between insulin injection and eating. Of the remainder, 67 (33%) admitted disregarding advice and using shorter intervals. There was a significant (p less than 0.01) difference between the reported frequencies of clinical hypoglycaemia in patients using different intervals. The effects on glucose control of intervals between insulin injection and breakfast of zero, 15, 30, and 45 minutes were studied for periods of one week in 11 patients with type I diabetes who were receiving twice daily injections of monocomponent porcine insulins and high fibre, high carbohydrate diets, using standard home blood glucose monitoring techniques to measure blood glucose concentrations each morning. The delay of 45 minutes resulted in the lowest frequency of hypoglycaemia and the most acceptable pattern of glucose concentrations measured one and two hours after breakfast and before lunch. Combining results obtained at these three times, the mean increment in blood glucose concentration was smaller after allowing a delay of 45 minutes than after delays of zero (p less than 0.001), 15 (p less than 0.03), and 30 (NS) minutes. A delay of 30 minutes resulted in smaller mean increments in blood glucose concentration than did delays of zero (p less than 0.001) and 15 (NS) minutes. These results suggest that this aspect of diabetic management may be neglected, with important consequences for blood glucose control. An increase in delay between insulin injection and eating to 45 minutes would be a simple and safe way of improving blood glucose control in at least the 37% of the diabetic population surveyed in this study who currently allow less than 15 minutes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917700      PMCID: PMC1415461          DOI: 10.1136/bmj.290.6462.105

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  25 in total

1.  Nocturnal hypoglycaemia and haemoglobin A1.

Authors:  E A Gale; S Walford; R B Tattersall
Journal:  Lancet       Date:  1979-12-08       Impact factor: 79.321

Review 2.  Relation of diabetic control to development of microvascular complications.

Authors:  G Tchobroutsky
Journal:  Diabetologia       Date:  1978-09       Impact factor: 10.122

3.  A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements.

Authors:  M Phillips; R W Simpson; R R Holman; R C Turner
Journal:  Q J Med       Date:  1979-07

4.  Control of blood glucose and diabetic vascular disease.

Authors:  M D Siperstein; D W Foster; H C Knowles; R Levine; L L Madison; J Roth
Journal:  N Engl J Med       Date:  1977-05-05       Impact factor: 91.245

5.  Home blood glucose monitoring.

Authors:  R B Tattersall
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

6.  Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity.

Authors:  D J Jenkins; T M Wolever; A R Leeds; M A Gassull; P Haisman; J Dilawari; D V Goff; G L Metz; K G Alberti
Journal:  Br Med J       Date:  1978-05-27

7.  Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site.

Authors:  M Berger; P A Halban; L Girardier; J Seydoux; R E Offord; A E Renold
Journal:  Diabetologia       Date:  1979-08       Impact factor: 10.122

8.  Effects of leg exercise on insulin absorption in diabetic patients.

Authors:  V A Koivisto; P Felig
Journal:  N Engl J Med       Date:  1978-01-12       Impact factor: 91.245

9.  Self-monitoring of blood-glucose. Improvement of diabetic control.

Authors:  S Walford; E A Gale; S P Allison; R B Tattersall
Journal:  Lancet       Date:  1978-04-08       Impact factor: 79.321

10.  Fiber and diabetes.

Authors:  J W Anderson; W R Midgley; B Wedman
Journal:  Diabetes Care       Date:  1979 Jul-Aug       Impact factor: 19.112

View more
  6 in total

1.  Nice insulins, pity about the evidence.

Authors:  F Holleman; E A M Gale
Journal:  Diabetologia       Date:  2007-09       Impact factor: 10.122

Review 2.  Biphasic insulin aspart in type 2 diabetes mellitus: an evidence-based medicine review.

Authors:  S C L Gough; J Tibaldi
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

3.  Pharmacokinetic and pharmacodynamic properties of insulin aspart and human insulin.

Authors:  Ole Østerberg; Lars Erichsen; Steen H Ingwersen; Anne Plum; Henrik E Poulsen; Paolo Vicini
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-06       Impact factor: 2.745

4.  Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.

Authors:  J P Vora; D R Owens; J Dolben; J A Atiea; J D Dean; S Kang; A Burch; J Brange
Journal:  BMJ       Date:  1988-11-12

5.  Insulin--sniffing for jabbing.

Authors:  C Fox
Journal:  J R Soc Med       Date:  1991-12       Impact factor: 18.000

6.  Randomized crossover study to examine the necessity of an injection-to-meal interval in patients with type 2 diabetes and human insulin.

Authors:  Nicolle Müller; Thomas Frank; Christof Kloos; Thomas Lehmann; Gunter Wolf; Ulrich Alfons Müller
Journal:  Diabetes Care       Date:  2013-01-22       Impact factor: 19.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.